Terms: = Myeloproliferative Neoplasm AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
1182 results:
1. [Genetic Variation of
Ma Q; Hu RH; Zhao H; Lan XX; Guo YX; Chang XL; Sun WL; Su L; Hui WH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1186-1190. PubMed ID: 39192417
[TBL] [Abstract] [Full Text] [Related]
2. Myeloid sarcoma in JAK2-positive myelodysplastic neoplasms with fibrosis: a case report and literature review.
Bai J; Wang X; Zheng R; He M; Zhang Y; Zhang Z; Yang X; Pan Y
J Int Med Res; 2024 Aug; 52(8):3000605241266590. PubMed ID: 39088684
[TBL] [Abstract] [Full Text] [Related]
3. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation.
Méhes G; Mokánszki A; Ujfalusi A; Hevessy Z; Miltényi Z; Gergely L; Bedekovics J
Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063245
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Characteristics and Diagnosis of Nonaccelerating mds/MPN-U Patient with Granulocyte Dysplasia.
Jin N; Li S
Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965949
[TBL] [Abstract] [Full Text] [Related]
5. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists.
Moore ME; Williams E; Pelkey L; Courville EL
Cancer Genet; 2024 Aug; 286-287():25-28. PubMed ID: 38964162
[TBL] [Abstract] [Full Text] [Related]
6. miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia.
Poggio P; Rocca S; Fusella F; Ferretti R; Ala U; D'Anna F; Giugliano E; Panuzzo C; Fontana D; Palumbo V; Carrà G; Taverna D; Gambacorti-Passerini C; Saglio G; Fava C; Piazza R; Morotti A; Orso F; Brancaccio M
Sci Rep; 2024 Jul; 14(1):15089. PubMed ID: 38956394
[TBL] [Abstract] [Full Text] [Related]
7. NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.
Ye X; Zheng Z; Wu Y; Zhang Z; Xu Z; Liu Y; Jiang L; Wu J
Medicine (Baltimore); 2024 Jun; 103(24):e38556. PubMed ID: 38875377
[TBL] [Abstract] [Full Text] [Related]
8. Decreased spermatogonial numbers in boys with severe haematological diseases.
Lahtinen AK; Funke M; Krallmann C; Wyrwoll MJ; Jarisch A; Yang Y; Bjarnason R; Romerius P; Sundin M; Norén-Nyström U; Langenskiöld C; Cremers JF; Kliesch S; Stukenborg JB; Neuhaus N; Jahnukainen K
Br J Haematol; 2024 Jul; 205(1):229-235. PubMed ID: 38810989
[TBL] [Abstract] [Full Text] [Related]
9. Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated mds and mds/MPN.
Montalban-Bravo G; Jabbour E; Chien K; Hammond D; Short N; Ravandi F; Konopleva M; Borthakur G; Daver N; Kanagal-Shammana R; Loghavi S; Qiao W; Huang X; Schneider H; Meyer M; Kantarjian H; Garcia-Manero G
Leuk Res; 2024 Jul; 142():107518. PubMed ID: 38744144
[TBL] [Abstract] [Full Text] [Related]
10. Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
Li F; Qin T; Li B; Qu S; Pan L; Zhang P; Sun Q; Cai W; Gao Q; Jiao M; Li J; Ai X; Ma J; Gale RP; Xu Z; Xiao Z
Leukemia; 2024 Jun; 38(6):1334-1341. PubMed ID: 38714876
[TBL] [Abstract] [Full Text] [Related]
11. Evaluating targeted therapies in older patients with
Sabile JMG; Swords R; Tyner JW
Leuk Lymphoma; 2024 Sep; 65(9):1201-1218. PubMed ID: 38646877
[TBL] [Abstract] [Full Text] [Related]
12. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N; Orazi A; Tefferi A
Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Kim SY; Song IC; Kim J; Kwon GC
Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
[TBL] [Abstract] [Full Text] [Related]
14. Role of reactive oxygen species in myelodysplastic syndromes.
Jing Q; Zhou C; Zhang J; Zhang P; Wu Y; Zhou J; Tong X; Li Y; Du J; Wang Y
Cell Mol Biol Lett; 2024 Apr; 29(1):53. PubMed ID: 38616283
[TBL] [Abstract] [Full Text] [Related]
15. [Study of a patient with Myelodysplastic/myeloproliferative neoplasm with co-morbid neutrophilia and a novel NCOR1::GLYR1 fusion gene].
Lei Y; Zhao X; Zhao H; Cheng Y; Wang S; Li J; Zhu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Apr; 41(4):404-410. PubMed ID: 38565504
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm.
Beckmann CCA; Ramamoorthy S; Trompouki E; Driever W; Schwarz-Furlan S; Strahm B; Yoshimi A; Niemeyer CM; Erlacher M; Kapp FG
Exp Hematol; 2024 May; 133():104207. PubMed ID: 38522505
[TBL] [Abstract] [Full Text] [Related]
17. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation.
Zhu P; Lai X; Liu L; Shi J; Yu J; Zhao Y; Yang L; Yang T; Zheng W; Sun J; Wu W; Zhao Y; Cai Z; Huang H; Luo Y
J Transl Med; 2024 Mar; 22(1):275. PubMed ID: 38481248
[TBL] [Abstract] [Full Text] [Related]
18. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract] [Full Text] [Related]
19. Myelodysplastic Syndromes and Myelodysplastic Syndromes/myeloproliferative neoplasms: A Real-World Experience From a Developing Country.
Awidi A; Alzu'bi M; Odeh N; Alrawabdeh J; Al Zyoud M; Hamadneh Y; Bawa'neh H; Magableh A; Alshorman A; Al-Fararjeh F; Aladily T; Zeidan AM
JCO Glob Oncol; 2024 Feb; 10():e2300281. PubMed ID: 38422464
[TBL] [Abstract] [Full Text] [Related]
20. Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid neoplasms".
Kok CH; Yeung DT; Hiwase DK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396733
[TBL] [Abstract] [Full Text] [Related]
[Next]
